- Home
- NGS vs SLN Comparison
NGS vs SLN Comparison
Compare NGS & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGS
- SLN
- Stock Information
- Founded
- NGS 1998
- SLN 1994
- Country
- NGS United States
- SLN United Kingdom
- Employees
- NGS N/A
- SLN N/A
- Industry
- NGS Oilfield Services/Equipment
- SLN Biotechnology: Pharmaceutical Preparations
- Sector
- NGS Energy
- SLN Health Care
- Exchange
- NGS Nasdaq
- SLN Nasdaq
- Market Cap
- NGS 326.3M
- SLN 223.4M
- IPO Year
- NGS 2002
- SLN N/A
- Fundamental
- Price
- NGS $22.13
- SLN $4.06
- Analyst Decision
- NGS Strong Buy
- SLN Buy
- Analyst Count
- NGS 2
- SLN 5
- Target Price
- NGS $26.50
- SLN $40.80
- AVG Volume (30 Days)
- NGS 65.5K
- SLN 217.1K
- Earning Date
- NGS 03-17-2025
- SLN 02-27-2025
- Dividend Yield
- NGS N/A
- SLN N/A
- EPS Growth
- NGS 605.21
- SLN N/A
- EPS
- NGS 1.28
- SLN N/A
- Revenue
- NGS $152,305,000.00
- SLN $43,258,000.00
- Revenue This Year
- NGS $30.81
- SLN N/A
- Revenue Next Year
- NGS $13.48
- SLN N/A
- P/E Ratio
- NGS $17.28
- SLN N/A
- Revenue Growth
- NGS 41.72
- SLN 36.71
- 52 Week Low
- NGS $16.70
- SLN $3.99
- 52 Week High
- NGS $29.74
- SLN $27.72
- Technical
- Relative Strength Index (RSI)
- NGS 36.21
- SLN 35.26
- Support Level
- NGS $20.22
- SLN $4.06
- Resistance Level
- NGS $25.85
- SLN $4.90
- Average True Range (ATR)
- NGS 1.14
- SLN 0.40
- MACD
- NGS -0.26
- SLN 0.00
- Stochastic Oscillator
- NGS 29.48
- SLN 5.43
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.